Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Survival analysis of all 533 patients allocated to intracoronary streptokinase or conventional therapy (control). Numbers denote patients at risk at the various intervals after treatment with streptokinase (top) or conventional therapy (below). Follow-up data were complete at three years. From Simoons et al. (7).
|
